Intellipharmaceutics International Inc IPCIF
$0.00
Last Updated: Oct 03, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
IPCIF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Intellipharmaceutics International Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Intellipharmaceutics International Inc. Stock Analysis IPCIF
United States Health Care Nano Cap Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company is headquartered in Etobicoke, Ontario and currently employs 11 full-time employees. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. The company has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The firm has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.
Intellipharmaceutics International Inc (IPCIF) Chart
Financial Metrics & Statements of Intellipharmaceutics International Inc (IPCIF)
FAQ's for Intellipharmaceutics International Inc (IPCIF)
- As of August 2026, Intellipharmaceutics International Inc IPCIF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Intellipharmaceutics International Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Intellipharmaceutics International Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Intellipharmaceutics International Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Intellipharmaceutics International Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Intellipharmaceutics International Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Intellipharmaceutics International Inc (IPCIF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
